
Howard Colman, MD, PhD, discusses the STELLAR trial of eflornithine plus lomustine vs lomustine alone in recurrent, IDH-mutant, anaplastic astrocytoma.

Your AI-Trained Oncology Knowledge Connection!


Howard Colman, MD, PhD, is the Jan M. Huntsman Presidential Professor in the Department of Neurosurgery, member of the Brain Tumor Research Team, and leader of the Center for Neurologic Cancers at Huntsman Cancer Institute, of the University of Utah.